{"transactions":[{"id":1005427,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T16:18:38.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":13790,"price":6.8,"value":93772.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":13790,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":13790},"source":{"system":"sec-edgar","filing":"0001628280-25-050491","document":"wk-form4_1762532316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050491/wk-form4_1762532316.xml","form_type":"4"}},{"id":1362820,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T16:18:53.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":21590,"price":4.64,"value":100177.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":21590,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":21590},"source":{"system":"sec-edgar","filing":"0001628280-24-048205","document":"wk-form4_1731946727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048205/wk-form4_1731946727.xml","form_type":"4"}},{"id":1679548,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-16T16:45:44.000Z","date":"2024-01-12","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.5,"value":6500.0,"ownership":{"direct":true},"balance_after":198625,"source":{"system":"sec-edgar","filing":"0001628280-24-001334","document":"wk-form4_1705423535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001334/wk-form4_1705423535.xml","form_type":"4"}},{"id":1680382,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-12T17:47:07.000Z","date":"2024-01-11","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.27,"value":12540.0,"ownership":{"direct":true},"balance_after":197625,"source":{"system":"sec-edgar","filing":"0001628280-24-001231","document":"wk-form4_1705081618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001231/wk-form4_1705081618.xml","form_type":"4"}},{"id":1681150,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-11T15:57:35.000Z","date":"2024-01-10","kind":"purchase","planned":false,"acquired":true,"shares":2944,"price":6.31,"value":18576.64,"ownership":{"direct":true},"balance_after":195625,"source":{"system":"sec-edgar","filing":"0001628280-24-001118","document":"wk-form4_1704988646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001118/wk-form4_1704988646.xml","form_type":"4"}},{"id":1682049,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-10T13:57:40.000Z","date":"2024-01-09","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":6.25,"value":18750.0,"ownership":{"direct":true},"balance_after":192681,"source":{"system":"sec-edgar","filing":"0001628280-24-001002","document":"wk-form4_1704895046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024001002/wk-form4_1704895046.xml","form_type":"4"}},{"id":1683391,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T14:08:15.000Z","date":"2024-01-08","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":6.15,"value":6150.0,"ownership":{"direct":true},"balance_after":189681,"source":{"system":"sec-edgar","filing":"0001628280-24-000896","document":"wk-form4_1704809286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000896/wk-form4_1704809286.xml","form_type":"4"}},{"id":1684873,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T20:11:57.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.09,"value":12180.0,"ownership":{"direct":true},"balance_after":188681,"source":{"system":"sec-edgar","filing":"0001628280-24-000825","document":"wk-form4_1704744709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000825/wk-form4_1704744709.xml","form_type":"4"}},{"id":1684872,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-08T19:54:56.000Z","date":"2024-01-04","kind":"purchase","planned":false,"acquired":true,"shares":3000,"price":6.12,"value":18360.0,"ownership":{"direct":true},"balance_after":186681,"source":{"system":"sec-edgar","filing":"0001628280-24-000820","document":"wk-form4_1704743687.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000820/wk-form4_1704743687.xml","form_type":"4"}},{"id":1689902,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T18:37:03.000Z","date":"2024-01-03","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":5.83,"value":2915.0,"ownership":{"direct":true},"balance_after":183681,"source":{"system":"sec-edgar","filing":"0001628280-24-000388","document":"wk-form4_1704393413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024000388/wk-form4_1704393413.xml","form_type":"4"}},{"id":1700480,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-26T16:48:13.000Z","date":"2023-12-21","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":4.92,"value":12300.0,"ownership":{"direct":true},"balance_after":183181,"source":{"system":"sec-edgar","filing":"0001628280-23-042662","document":"wk-form4_1703609285.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042662/wk-form4_1703609285.xml","form_type":"4"}},{"id":1702841,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-21T19:31:13.000Z","date":"2023-12-20","kind":"purchase","planned":false,"acquired":true,"shares":2100,"price":4.82,"value":10122.0,"ownership":{"direct":true},"balance_after":180681,"source":{"system":"sec-edgar","filing":"0001628280-23-042467","document":"wk-form4_1703187064.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042467/wk-form4_1703187064.xml","form_type":"4"}},{"id":1703839,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-20T14:48:53.000Z","date":"2023-12-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.75,"value":23750.0,"ownership":{"direct":true},"balance_after":178581,"source":{"system":"sec-edgar","filing":"0001628280-23-042096","document":"wk-form4_1703083724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023042096/wk-form4_1703083724.xml","form_type":"4"}},{"id":1748202,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:58:37.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":26220,"price":5.51,"value":144472.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":26220,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":26220},"source":{"system":"sec-edgar","filing":"0001628280-23-037249","document":"wk-form4_1699376309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037249/wk-form4_1699376309.xml","form_type":"4"}},{"id":1760252,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:53:56.000Z","date":"2023-09-29","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":6.16,"value":24640.0,"ownership":{"direct":true},"balance_after":173581,"source":{"system":"sec-edgar","filing":"0001628280-23-034409","document":"wk-form4_1697464428.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034409/wk-form4_1697464428.xml","form_type":"4"}},{"id":1760251,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:52:39.000Z","date":"2023-09-28","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.22,"value":31100.0,"ownership":{"direct":true},"balance_after":169581,"source":{"system":"sec-edgar","filing":"0001628280-23-034407","document":"wk-form4_1697464350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034407/wk-form4_1697464350.xml","form_type":"4"}},{"id":1760250,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T13:51:00.000Z","date":"2023-09-27","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":5.95,"value":8925.0,"ownership":{"direct":true},"balance_after":164581,"source":{"system":"sec-edgar","filing":"0001628280-23-034405","document":"wk-form4_1697464252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034405/wk-form4_1697464252.xml","form_type":"4"}},{"id":1760874,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-13T16:48:11.000Z","date":"2023-10-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.4,"value":32000.0,"ownership":{"direct":true},"balance_after":163081,"source":{"system":"sec-edgar","filing":"0001628280-23-034348","document":"wk-form4_1697215682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034348/wk-form4_1697215682.xml","form_type":"4"}},{"id":1762207,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-11T13:45:07.000Z","date":"2023-10-10","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":6.41,"value":7051.0,"ownership":{"direct":true},"balance_after":158081,"source":{"system":"sec-edgar","filing":"0001628280-23-034231","document":"wk-form4_1697031899.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034231/wk-form4_1697031899.xml","form_type":"4"}},{"id":1763096,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-10T14:02:13.000Z","date":"2023-10-06","kind":"purchase","planned":false,"acquired":true,"shares":1530,"price":6.48,"value":9914.4,"ownership":{"direct":true},"balance_after":156981,"source":{"system":"sec-edgar","filing":"0001628280-23-034119","document":"wk-form4_1696946525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034119/wk-form4_1696946525.xml","form_type":"4"}},{"id":1764044,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-06T11:10:55.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":6.47,"value":12940.0,"ownership":{"direct":true},"balance_after":155451,"source":{"system":"sec-edgar","filing":"0001628280-23-034004","document":"wf-form4_169659064199177.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023034004/wf-form4_169659064199177.xml","form_type":"4"}},{"id":1766141,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:31:08.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":6.3,"value":15750.0,"ownership":{"direct":true},"balance_after":148451,"source":{"system":"sec-edgar","filing":"0001628280-23-033843","document":"wf-form4_169645505352839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033843/wf-form4_169645505352839.xml","form_type":"4"}},{"id":1766140,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T21:30:36.000Z","date":"2023-10-04","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.4,"value":32000.0,"ownership":{"direct":true},"balance_after":153451,"source":{"system":"sec-edgar","filing":"0001628280-23-033842","document":"wf-form4_169645502108268.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033842/wf-form4_169645502108268.xml","form_type":"4"}},{"id":1772963,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-27T13:56:59.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.65,"value":28250.0,"ownership":{"direct":true},"balance_after":145951,"source":{"system":"sec-edgar","filing":"0001628280-23-033077","document":"wf-form4_169582300558310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023033077/wf-form4_169582300558310.xml","form_type":"4"}},{"id":1774313,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T19:00:00.000Z","date":"2023-09-19","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.28,"value":26400.0,"ownership":{"direct":true},"balance_after":128121,"source":{"system":"sec-edgar","filing":"0001628280-23-032920","document":"wf-form4_169566838737069.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032920/wf-form4_169566838737069.xml","form_type":"4"}},{"id":1774312,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:45.000Z","date":"2023-09-20","kind":"purchase","planned":false,"acquired":true,"shares":4018,"price":5.51,"value":22139.18,"ownership":{"direct":true},"balance_after":132139,"source":{"system":"sec-edgar","filing":"0001628280-23-032919","document":"wf-form4_169566837025005.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032919/wf-form4_169566837025005.xml","form_type":"4"}},{"id":1774311,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:26.000Z","date":"2023-09-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.51,"value":27550.0,"ownership":{"direct":true},"balance_after":137139,"source":{"system":"sec-edgar","filing":"0001628280-23-032918","document":"wf-form4_169566835107905.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032918/wf-form4_169566835107905.xml","form_type":"4"}},{"id":1774310,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-25T18:59:08.000Z","date":"2023-09-22","kind":"purchase","planned":false,"acquired":true,"shares":3812,"price":5.5,"value":20966.0,"ownership":{"direct":true},"balance_after":140951,"source":{"system":"sec-edgar","filing":"0001628280-23-032917","document":"wf-form4_169566833604307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023032917/wf-form4_169566833604307.xml","form_type":"4"}},{"id":1804747,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:07:58.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":19430,"price":7,"value":136010.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":19430,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":19430},"source":{"system":"sec-edgar","filing":"0001628280-23-029777","document":"wf-form4_169228846413492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029777/wf-form4_169228846413492.xml","form_type":"4"}},{"id":2520644,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:31:59.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":13614,"price":10.1,"value":137501.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":13614,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":13614},"source":{"system":"sec-edgar","filing":"0001628280-21-022606","document":"wf-form4_163649710448444.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022606/wf-form4_163649710448444.xml","form_type":"4"}},{"id":2950857,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-12-10T22:01:56.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":10000,"price":11.96,"value":119600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on December 8, 2020,  March 8, 2021, June 8, 2021 and September 8, 2021, respectively."}],"balance_after":10000,"derivative":{"exercise_price":11.96,"expiration_date":"2025-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-017368","document":"wf-form4_160763770404258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020017368/wf-form4_160763770404258.xml","form_type":"4"}},{"id":2995849,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":10000,"price":3.21,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vest and are exercisable over a nine month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8 2018, respectively."}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995848,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":10000,"price":1.59,"value":15900.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and are exercisable over a nine month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995847,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":false,"shares":10000,"price":5.46,"value":54600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a nine month period, with vesting to occur on November 2, 2015, February 2, 2016, May 2, 2016 and August 2, 2016, respectively."}],"balance_after":0,"derivative":{"exercise_price":5.46,"expiration_date":"2020-11-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995846,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":10000,"price":3.21,"value":32100.0,"ownership":{"direct":true},"balance_after":123121,"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995845,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":10000,"price":1.59,"value":15900.0,"ownership":{"direct":true},"balance_after":113121,"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995844,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T22:44:57.000Z","date":"2020-02-18","kind":"exercise","acquired":true,"shares":10000,"price":5.46,"value":54600.0,"ownership":{"direct":true},"balance_after":103121,"source":{"system":"sec-edgar","filing":"0001628280-20-015400","document":"wf-form4_160444348372369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015400/wf-form4_160444348372369.xml","form_type":"4"}},{"id":2995843,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant to purchase shares of Common Stock","published_at":"2020-11-03T22:39:41.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":34375,"price":5.76,"value":198000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"shares","element":"transactionShares","label":"F1","text":"Effective August 11, 2015, the Issuer effected a 1-for-12 reverse stock split of the Issuer's Common Stock (the \"Reverse Stock Split\"). All share numbers and the exercise price of the warrants reported herein give effect to the Reverse Stock Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were immediately exercisable upon grant on March 13, 2015."}],"balance_after":0,"derivative":{"exercise_price":5.76,"exercise_date":"2015-03-13","expiration_date":"2020-03-13","underlying":"Common Stock","underlying_shares":34375},"source":{"system":"sec-edgar","filing":"0001628280-20-015396","document":"wf-form4_160444316482521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015396/wf-form4_160444316482521.xml","form_type":"4"}},{"id":2995842,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-03T22:39:41.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":34375,"price":5.76,"value":198000.0,"ownership":{"direct":true},"balance_after":103121,"source":{"system":"sec-edgar","filing":"0001628280-20-015396","document":"wf-form4_160444316482521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020015396/wf-form4_160444316482521.xml","form_type":"4"}},{"id":3192562,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T20:56:14.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":300,"price":5.89,"value":1767.0,"ownership":{"direct":true},"balance_after":58746,"source":{"system":"sec-edgar","filing":"0001628280-20-004374","document":"wf-form4_158560175582059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/wf-form4_158560175582059.xml","form_type":"4"}},{"id":3192561,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T20:56:14.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":700,"price":5.9,"value":4130.0,"ownership":{"direct":true},"balance_after":58446,"source":{"system":"sec-edgar","filing":"0001628280-20-004374","document":"wf-form4_158560175582059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/wf-form4_158560175582059.xml","form_type":"4"}},{"id":3192560,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T20:56:14.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":100,"price":5.97,"value":597.0,"ownership":{"direct":true},"balance_after":57746,"source":{"system":"sec-edgar","filing":"0001628280-20-004374","document":"wf-form4_158560175582059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/wf-form4_158560175582059.xml","form_type":"4"}},{"id":3192559,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T20:56:14.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":100,"price":5.99,"value":599.0,"ownership":{"direct":true},"balance_after":57646,"source":{"system":"sec-edgar","filing":"0001628280-20-004374","document":"wf-form4_158560175582059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/wf-form4_158560175582059.xml","form_type":"4"}},{"id":3192558,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-30T20:56:14.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":20,"price":6,"value":120.0,"ownership":{"direct":true},"balance_after":57546,"source":{"system":"sec-edgar","filing":"0001628280-20-004374","document":"wf-form4_158560175582059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004374/wf-form4_158560175582059.xml","form_type":"4"}},{"id":3194805,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-26T19:00:49.000Z","date":"2020-03-24","kind":"purchase","acquired":true,"shares":26,"price":5.5,"value":143.0,"ownership":{"direct":true},"balance_after":57526,"source":{"system":"sec-edgar","filing":"0001628280-20-004087","document":"wf-form4_158524923075589.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020004087/wf-form4_158524923075589.xml","form_type":"4"}},{"id":3379383,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2019-11-06T22:18:20.000Z","date":"2019-11-04","kind":"grant","acquired":true,"shares":10000,"price":5.43,"value":54300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019,  February 4, 2020, May 4, 2020 and August 4, 2020, respectively."}],"balance_after":10000,"derivative":{"exercise_price":5.43,"expiration_date":"2024-11-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-19-013533","document":"wf-form4_157307868493803.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828019013533/wf-form4_157307868493803.xml","form_type":"4"}},{"id":3771079,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T22:02:32.000Z","date":"2018-11-06","kind":"sale","acquired":false,"shares":5000,"price":13.75,"value":68750.0,"ownership":{"direct":true},"balance_after":57500,"source":{"system":"sec-edgar","filing":"0001628280-18-014013","document":"wf-form4_154171453610938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828018014013/wf-form4_154171453610938.xml","form_type":"4"}},{"id":3774935,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2018-11-05T16:39:28.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":10000,"price":12.73,"value":127300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018,  February 1, 2019, May 1, 2019 and August 1, 2019, respectively."}],"balance_after":10000,"derivative":{"exercise_price":12.73,"expiration_date":"2023-11-01","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-18-013556","document":"wf-form4_154143595175126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828018013556/wf-form4_154143595175126.xml","form_type":"4"}},{"id":3796414,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-05T14:30:58.000Z","date":"2018-09-20","kind":"sale","acquired":false,"shares":8333,"price":13.02,"value":108495.66,"ownership":{"direct":true},"balance_after":62500,"source":{"system":"sec-edgar","filing":"0001628280-18-012338","document":"wf-form4_153874984226796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828018012338/wf-form4_153874984226796.xml","form_type":"4"}},{"id":4568729,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":73485,"kind":"person","name":"Mendelson Daniel Newman","position":1,"cik":"0001327897","reported_name":"Mendelson Daniel Newman","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2016-11-03T18:31:08.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016,  February 1, 2017, May 1, 2017 and August 1, 2017, respectively."}],"balance_after":10000,"derivative":{"exercise_price":1.59,"expiration_date":"2021-10-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001144204-16-131340","document":"v452158_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000114420416131340/v452158_4.xml","form_type":"4"}}]}